drugset
drugset / Trial / NCT05324631

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis

NCT05324631 ↗

Phase 3 Unknown 300 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to evaluate the efficacy and safety of SHR0302 in subjects with active non-radiographic axial spondyloarthritis.

Timeline

Start
2022-08-16
Primary completion
2024-08-30
Completion
2024-12-11

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR0302 Unknown — Oral

Indications

spondyloarthropathy